IMARC Group, a leading market research company, has recently releases report titled “Synthetic Biology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global synthetic biology market report, growth, share, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Industry Overview of Synthetic Biology

Synthetic biology is an interdisciplinary field of biology that combines principles from biology, engineering, and computer science to design, construct, and manipulate biological systems or organisms to achieve specific capabilities. It involves the synthesis of natural components and the reconfiguration of existing genetic material to create artificial biological systems. It emphasizes the use of standardized, interchangeable biological parts, enabling the construction of complex systems from simpler components. It allows precise control over genetic sequences and gene expression, facilitating the fine-tuning of bodily functions. It stimulates the sustainable production of biofuels, chemicals, and materials using renewable resources. It can lead to the development of new therapies, drugs, and vaccines, including personalized medicine. It enhances crop yields, creates disease-resistant plants, and develops nutritious foods. It fosters innovation in biotechnology, accelerating the development of new products and technologies. It is widely used for developing organisms that can break down pollutants and clean up contaminated sites.

How Big Is the Synthetic Biology Market?

The global synthetic biology market size reached US$ 13.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 38.8 Billion by 2028, exhibiting a growth rate (CAGR) of 18.1% during 2023-2028.

Request Sample Copy of This Report: https://www.imarcgroup.com/synthetic-biology-market/requestsample

What are the growth prospects and trends in the synthetic biology industry?

The escalating demand for sustainable solutions across various industries due to growing environmental concerns represents one of the primary factors facilitating the market growth. Synthetic biology enables the development of microorganisms to produce biofuels, chemicals, and materials from renewable feedstocks, reducing dependence on fossil fuels and mitigating environmental impact.

Apart from this, the development of high-throughput DNA synthesis and gene-editing technologies, particularly CRISPR-Cas9, is making it more accessible and cost-effective. These tools empower researchers to design and engineer biological systems with greater precision, predictability, and efficiency. Furthermore, the rising prevalence of chronic diseases and the increasing need for targeted treatments is another significant factor stimulating the market growth. Synthetic biology enables the design of custom genetic constructs and biologically derived therapeutics, offering unprecedented opportunities for drug discovery and development.

Moreover, the growing adoption of synthetic biology in environmental applications is strengthening the growth of the market. Besides this, the expansion of synthetic biology into novel domains, such as synthetic genomics and bioinformatics, is influencing the market positively.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

• Oligonucleotide/Oligo Pools and Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Xeno-nucleic Acids
• Chassis Organism

Breakup by Technology:

• NGS Technology
• PCR Technology
• Genome Editing Technology
• Bioprocessing Technology
• Others

Breakup by Application:

• Healthcare
  • Clinical
  • Non-Clinical/Research
• Non-Healthcare
  • Biotech Crops
  • Specialty Chemicals
  • Bio-Fuels
  • Others

Breakup by Region:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

• Agilent Technologies Inc.
• Amyris Inc.
• Codexis Inc.
• Danaher Corporation
• Eurofins Scientific
• GenScript Biotech Corporation
• Illumina Inc.
• Merck KGaA
• New England Biolabs
• Synthego Corporation
• Thermo Fisher Scientific Inc.
• Twist Bioscience
• Viridos Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/